TrademarkDir
CYPRIUM THERAPEUTICS
LIVE

Serial Number

87372166

Owner

Cyprium Therapeutics, Inc.

Attorney

Devon E. White

First Use Date

Jan 25, 2019

Filing Date

Mar 15, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CYPRIUM THERAPEUTICS Trademark

Serial Number: 87372166 • Registration: 6341812

CYPRIUM THERAPEUTICS is a trademark filed by Cyprium Therapeutics, Inc. on March 15, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Cyprium Therapeutics, Inc. (2 trademarks)

New York, NY 10014

Entity Type: 03

Trademark Details

Filing Date

March 15, 2017

Registration Date

May 4, 2021

First Use Anywhere

January 25, 2019

First Use in Commerce

January 25, 2019

Published for Opposition

February 13, 2018

Goods & Services

Pharmaceutical preparations for human use for the treatment of Menkes disease and copper transport and metabolism diseases and disorders; Pharmaceutical preparations for human use for the treatment of diseases and disorders where copper deficiency is present; Pharmaceutical preparations for human use for the treatment of hematological and neurological disorders

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 4, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
May 4, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 27, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 26, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 17, 2021 SUPC
USE AMENDMENT FILED
Mar 15, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 15, 2021 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2020 EXRA
SOU EXTENSION 5 GRANTED
Oct 20, 2020 EX5G
SOU EXTENSION 5 FILED
Oct 8, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 8, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 10, 2020 EXRA
SOU EXTENSION 4 GRANTED
Apr 8, 2020 EX4G
SOU EXTENSION 4 FILED
Apr 8, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 8, 2020 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 14, 2019 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 12, 2019 EXRA
SOU EXTENSION 3 GRANTED
Oct 10, 2019 EX3G
SOU EXTENSION 3 FILED
Oct 10, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 10, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 19, 2019 EXRA
SOU EXTENSION 2 GRANTED
Mar 15, 2019 EX2G
SOU EXTENSION 2 FILED
Mar 15, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 15, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 26, 2018 EXRA
CORRECTED NOA E-MAILED
Oct 26, 2018 NOAC
SOU EXTENSION 1 GRANTED
Oct 25, 2018 EX1G
DIVISIONAL PROCESSING COMPLETE
Oct 25, 2018 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 26, 2018 AITU
SOU EXTENSION 1 FILED
Sep 24, 2018 EXT1
DIVISIONAL REQUEST RECEIVED
Sep 24, 2018 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Sep 24, 2018 ERTD
SOU TEAS EXTENSION RECEIVED
Sep 24, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 10, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2018 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 3, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 3, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 3, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 2, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jan 2, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jan 2, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 14, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 13, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jun 13, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jun 13, 2017 CNRT
ASSIGNED TO EXAMINER
Jun 8, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 21, 2017 NWOS
NEW APPLICATION ENTERED
Mar 18, 2017 NWAP

Related Trademarks

More from this Owner

CYPRIUM THERAPEUTICS

CYPRIUM THERAPEUTICS

CYPRIUM THERAPEUTICS

CYPRIUM THERAPEUTICS

CYPRIUM THERAPEUTICS

CYPRIUM THERAPEUTICS